Deficiency of cholesteryl ester transfer protein. Description of the molecular defect and the dissociation of cholesteryl ester and triglyceride transport in plasma.

A patient is described who exhibited, despite excessively high postprandial triglyceride levels, high levels of HDL cholesterol. Measurement of CETP activity and mass in the patient's plasma showed values of less than 5% and 2%, respectively, of a normolipidemic plasma pool. The CETP cDNA of the patient exhibited a mutation (T-->G), turning codon 57 (TAT) of exon 2 into a stop codon (TAG) and abolishing a, XcmI restriction site. Digestion of directly amplified CETP cDNA from the patient with XcmI indicated the exclusive presence of CETP cDNA containing the mutation. Analysis of the corresponding region of the CETP gene indicated the patient to be heterozygous for the nonsense mutation at codon 57, a finding that can only be explained by the presence of a null allele in addition to the allele with the nonsense mutation. The combination of TG intolerance of uncertain cause, together with CETP deficiency due to a novel mutation, produced the paradoxical constellation--high levels of HDL cholesterol (172 mg/dL) associated with a high post-prandial lipemia of 1460 mg triglycerides/dL.8 hours--and provided further insight into the role of CETP as mediator between pools of triglycerides and cholesteryl esters in plasma.

[1]  J. Groener,et al.  Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. , 1986, Clinical chemistry.

[2]  S. Yamashita,et al.  Detection of two species of low density lipoprotein particles in cholesteryl ester transfer protein deficiency. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[3]  R. Krauss,et al.  Nondenaturing polyacrylamide gradient gel electrophoresis. , 1986, Methods in enzymology.

[4]  P. Felgner,et al.  Cationic liposome-mediated transfection with lipofectin™ reagent. , 1991, Methods in molecular biology.

[5]  W C Willett,et al.  Low-density lipoprotein subclass patterns and risk of myocardial infarction. , 1988, JAMA.

[6]  D. B. Zilversmit,et al.  A plasma inhibitor of triglyceride and cholesteryl ester transfer activities. , 1981, The Journal of biological chemistry.

[7]  A. Gotto,et al.  A dual-precipitation method evaluated for measurement of cholesterol in high-density lipoprotein subfractions HDL2 and HDL3 in human plasma. , 1989, Clinical chemistry.

[8]  J. Ziegenhorn,et al.  Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. , 1983, Clinical chemistry.

[9]  A. Tall,et al.  Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. , 1990, The New England journal of medicine.

[10]  G. Reaven,et al.  Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity, and postprandial lipemia. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[11]  B. Luckow,et al.  CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements , 1987, Nucleic Acids Res..

[12]  J. Patsch,et al.  Separation of the main lipoprotein density classes from human plasma by rate-zonal ultracentrifugation. , 1974, Journal of lipid research.

[13]  W. Gruber,et al.  Reagent for the Enzymatic Determination of Serum Total Triglycerides with Improved Lipolytic Efficiency , 1984, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[14]  S. Yamashita,et al.  A novel nonsense mutation (G181X) in the human cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects. , 1996, Journal of lipid research.

[15]  D. B. Zilversmit,et al.  Purification and characterization of lipid transfer protein(s) from human lipoprotein-deficient plasma. , 1982, Journal of lipid research.

[16]  G. Utermann,et al.  Apolipoprotein E phenotyping from serum by Western blotting , 1986 .

[17]  M. Hayden,et al.  A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis , 1995, Nature Genetics.

[18]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[19]  G. Miller,et al.  PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE , 1975, The Lancet.

[20]  F. Lindgren,et al.  High density lipoprotein distribution. Resolution and determination of three major components in a normal population sample. , 1978, Atherosclerosis.

[21]  E. Gong,et al.  Characterization of human high-density lipoproteins by gradient gel electrophoresis. , 1981, Biochimica et biophysica acta.

[22]  K. Polonsky,et al.  Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities. , 1991, The Journal of clinical endocrinology and metabolism.

[23]  A. Gotto,et al.  Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[24]  G. R. Bartlett.  Phosphorus assay in column chromatography. , 1959, The Journal of biological chemistry.

[25]  J. Albers,et al.  Isolation and Characterization of Human Plasma Lipid Transfer Proteins , 1984, Arteriosclerosis.

[26]  P. Barter,et al.  Transfers and exchanges of esterified cholesterol between plasma lipoproteins. , 1982, The Biochemical journal.

[27]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[28]  B. Paulweber,et al.  Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. , 1993, The Journal of clinical investigation.

[29]  Y. Yazaki,et al.  Cholesteryl ester transfer protein deficiency caused by a nonsense mutation detected in the patient's macrophage mRNA. , 1993, Biochemical and biophysical research communications.

[30]  A. Tall,et al.  Organization of the human cholesteryl ester transfer protein gene. , 1990, Biochemistry.

[31]  H. Mabuchi,et al.  Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. , 1994, The Journal of clinical investigation.

[32]  S. Yamashita,et al.  Exon 10 skipping caused by intron 10 splice donor site mutation in cholesteryl ester transfer protein gene results in abnormal downstream splice site selection. , 1996, Journal of lipid research.

[33]  W. Kohr,et al.  Isolation and specificity of a Mr 74,000 cholesteryl ester transfer protein from human plasma. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Patsch,et al.  Plasma lipoprotein changes resulting from immunologically blocked lipolysis. , 1981, Journal of lipid research.

[35]  A. Tall,et al.  Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins , 1989, Nature.

[36]  A. Tall,et al.  Purification and characterization of a human plasma cholesteryl ester transfer protein. , 1987, The Journal of biological chemistry.

[37]  R. Margreiter,et al.  Effect of pancreas transplantation on lipoprotein lipase, postprandial lipemia, and HDL cholesterol. , 1994, Transplantation.

[38]  B. Groner,et al.  Lactogenic hormone and cell type-specific control of the whey acidic protein gene promoter in transfected mouse cells. , 1991, Molecular endocrinology.

[39]  M. Weintraub,et al.  Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. , 1987, The Journal of clinical investigation.

[40]  Arndt Rolfs,et al.  PCR: Clinical Diagnostics and Research , 1992 .

[41]  D. Gordon,et al.  High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. , 1989, Circulation.

[42]  J. Patsch,et al.  Triglyceride-rich lipoproteins and atherosclerosis. , 1994, Atherosclerosis.

[43]  S B Hulley,et al.  HDL Cholesterol and Other Lipids in Coronary Heart Disease: The Cooperative Lipoprotein Phenotyping Study , 1977, Circulation.

[44]  S. Schwarz,et al.  Polyclonal antibody-based immunoradiometric assay for quantification of cholesteryl ester transfer protein. , 1993, Journal of lipid research.